Hepatocellular Carcinoma Non-resectable Clinical Trials in Guangzhou, Guangdong
9 recruitingGuangzhou, Guangdong, China
Showing 1–9 of 9 trials
Recruiting
Phase 2
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University320 enrolled1 locationNCT06904183
Recruiting
Phase 2
Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University78 enrolled1 locationNCT06904196
Recruiting
Phase 2
DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University130 enrolled1 locationNCT06397235
Recruiting
Phase 3
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University178 enrolled1 locationNCT06492395
Recruiting
Phase 2
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria
Hepatocellular Carcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University29 enrolled1 locationNCT06607107
Recruiting
Phase 2
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University23 enrolled1 locationNCT06397222
Recruiting
Phase 3
Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University258 enrolled1 locationNCT05985798
Recruiting
Phase 3
Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University427 enrolled1 locationNCT05608200
Recruiting
Phase 3
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University187 enrolled1 locationNCT05608213